From my own perspective bioavailability is the highest effective biomedical quality of a product that can be provided to the patients specific condition. As an example a patient who has joint discomfort can be subscribed the precise formula of compounds to control the indication at the highest potential.
The compounds in cannabis are complex and will consistently improve through further study and trialling, even as far as providing a medical product personalised to the specific patient. Such as if 2 people were to suffer from epilepsy, the medical subscription would be customised dependant on the biological structure of the patient (genome).
It is complex but already happening.
- Forums
- ASX - By Stock
- HGV
- Yissum agreement
Yissum agreement, page-10
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add HGV (ASX) to my watchlist
|
|||||
Last
4.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.412M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 72432 | 4.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.4¢ | 10000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 72432 | 0.040 |
1 | 500000 | 0.039 |
1 | 26263 | 0.038 |
1 | 40000 | 0.035 |
2 | 58303 | 0.033 |
Price($) | Vol. | No. |
---|---|---|
0.044 | 10000 | 1 |
0.045 | 10520 | 2 |
0.047 | 20000 | 1 |
0.049 | 130000 | 2 |
0.050 | 52267 | 2 |
Last trade - 16.12pm 27/08/2024 (20 minute delay) ? |
Featured News
HGV (ASX) Chart |
Day chart unavailable
The Watchlist
SBW
SHEKEL BRAINWEIGH LTD
Dani Nadri, Country Manager Australia
Dani Nadri
Country Manager Australia
SPONSORED BY The Market Online